Related Experiment Video
Updated: Jan 21, 2026

Predicting Amputation using Local Circulating Mononuclear Progenitor Cells in Angioplasty-treated Patients with Critical Limb Ischemia
Published on: September 22, 2020
A Pro-Inflammatory Biomarker-Profile Predicts Amputation-Free Survival in Patients with Severe Limb Ischemia
Hendrik Gremmels1, Martin Teraa2,3, Saskia C A de Jager4
1Department of Nephrology and Hypertension, University Medical Center Utrecht, Utrecht, The Netherlands. h.gremmels@umcutrecht.nl.
Insights
Inflammatory biomarkers like IL-6 and IP-10 can predict major events, such as amputation or death, in patients with severe limb ischemia (SLI). These findings enable improved risk prediction models for SLI patients.
Area of Science:
- Biomarkers
- Vascular Medicine
- Inflammation
Background:
- Severe Limb Ischemia (SLI) presents a significant risk for amputation and mortality.
- Identifying reliable biomarkers is crucial for predicting disease progression and patient outcomes in SLI.
Purpose of the Study:
- To investigate a panel of serum biomarkers for predicting major adverse events in patients with established SLI.
- To develop and validate a biomarker-based risk prediction model for SLI.
Main Methods:
- Serum samples from 108 SLI patients (JUVENTAS cohort) were analyzed for 21 biomarkers.
- Major events (amputation or death) were the primary outcome.
- Results were validated in a secondary cohort of 146 patients using Cox regression and AUC analysis.
Main Results:
- Elevated levels of inflammatory biomarkers IL-6, IL-8, GROα, and IP-10 were associated with major endpoints.
- IL-6 and IP-10 were significant independent predictors of major events (aHRs ~1.4-1.5).
- A prediction model using IL-6 and IP-10 achieved ~78% AUC in both cohorts, outperforming previous models.
Conclusions:
- Specific inflammatory biomarkers, notably IL-6 and IP-10, effectively predict major adverse events in SLI.
- These biomarkers facilitate the development of accurate, risk-prediction models for SLI patients.
- This research offers a promising avenue for personalized risk assessment and management in SLI.
Abstract:
Patients with Severe Limb Ischemia (SLI) have a high risk of amputation and mortality. Here, we investigated a panel of serum biomarkers with the aim of identifying biomarkers for major events and mechanisms that contribute to disease progression in established SLI. A panel of biomarkers including GROα, HGF, SCF, SCGFβ, SDF1α, TRAIL, IL-6, IL-8, FGFβ, GCSF, GMCSF, IP10, MCP1, PDGFbb, RANTES, TNFα, VEGF, sICAM, sVCAM, TM, and E-selectin was measured in serum samples from a subset (n = 108) of the JUVENTAS cohort. The primary outcome was major events, defined as major amputation or death. The inflammatory biomarkers IL-6, IL-8, GROα and IP-10 were significantly elevated in patients who reached a major endpoint. Results were validated in a secondary cohort (n = 146). Cox regression showed that adjusted hazard ratios were 1.40 (95% CI: 1.15-1.70, p = 0.0007) and 1.48 (95% CI 1.16-1.87, p = 0.001) for IL-6 and IP-10 in a fully adjusted model containing both biomarkers. A prediction model using IL-6 and IP-10 showed predictive accuracy with an AUC of ~ 78% in both discovery and validation cohorts, which is higher than previously published models. We conclude that inflammatory biomarkers predict major events in patients with SLI and allow the creation of biomarker-based risk-prediction models.
Related Concept Videos
Predicting Molecular Geometry
Survival Tree
Building a Survival Tree
Constructing a...
Survival Curves
The Kaplan-Meier estimator is the most common method for constructing survival curves. This...
Inflammatory Response
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
Introduction To Survival Analysis
The primary goal of survival analysis is to estimate survival time—the time...
Comparing the Survival Analysis of Two or More Groups

